跳至主要内容
临床试验/NL-OMON35299
NL-OMON35299已完成不适用

Effects of N-3 fatty acids (DHA and EPA) on cognitive control and associated brain activity in ADHD: A double-blind placebo controlled study - N-3 fatty acids in ADHD

nilever0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • 1) 8-14 year old boys
  • 2) Used to daily consumption of margarine
  • 3) Sufficient mastery of the Dutch language of both the subject and his parents
  • ADHD-group:
  • 1)DSM-IV (APA, 1994) diagnosis of ADHD, according to DISC interview
  • 2) Scores in the clinical range on the Child Behaviour Checklist (CBCL) and Teacher Rating Form(TRF)

排除标准

  • 1) mental retardation (IQ < 70)
  • 2) major illness of the cardiovascular, the endocrine, the pulmonary or the gastrointestinal system
  • 3) presence of metal objects in or around the body (pacemaker, dental braces)
  • 4) history of or present neurological disorder
  • 5) regular use of n-3 or n-6 fatty acid dietary supplements, products fortified with EPA or DHA, a regular diet high in fatty fish in the four months prior to study participation

研究者

发起方
nilever

相似试验